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Obesity is a widespread problem within modern society, serving to increase the risk of cardiovascular, 
metabolic, and neurodegenerative disorders. Peroxisome proliferator-activated receptor gamma (PPARγ) and 
PPARγ coactivator 1 α (PGC1α) play a key role in the regulation of cellular energy metabolism and is 
implicated in the pathology of these diseases. This study examined the association between polymorphisms of 
the PPARG and PPARGC1A genes and individual variability in weight loss in response to physical activity 
intervention. 
METHODS AND RESULTSː 
Thirty-nine obese Ukrainian women (44.4 ± 7.5 years, BMI > 30.0 kg/m2) undertook a 3-month fitness 
program whilst following a hypocaloric diet (~1500 calories). Anthropometric and biochemical measurements 
took place before and after the program. Single nucleotide polymorphisms within or near PPARG (n=94) and 
PPARGC1A (n=138) were identified and expression of PPARG mRNA was measured via reverse transcription 
and amplification. The association between DNA polymorphisms and exercise-induced weight loss, initial 
body mass, biochemistry and PPARG expression was determined using one-way analysis of variance 
(ANOVA). 
The present intervention induced significant fat loss in all participants (total fat: 40.3±5.3 vs 36.4±5.7%; 
P<0.00001). Only one polymorphism (rs17650401 C/T) within the PPARGC1A gene was found to be 
associated with fat loss efficiency after correction for multiple testing, with T allele carriers showing the 
greatest reduction in body fat percentage (2.5-fold; P=0.00013) compared to non-carriers.  
CONCLUSIONSː   
PPARGC1A (rs17650401) is associated with fat loss efficiency of the fitness program in obese women. Further 
studies are warranted to test whether this variation is associated with fat oxidation. 
Key words:  
PPARG, obesity, peroxisome proliferator-activated receptor, Weight loss intervention, Single-nucleotide 
polymorphism 
Introduction 
Peroxisome proliferator-activated receptors (PPARs) are a group of nuclear receptors demonstrated to play a 
key role in carbohydrate and lipid metabolism, from the single cell to the whole organism. These receptors are 
classified into three families; PPAR, PPAR, and PPAR. PPAR controls lipid storage and synthesis[1]. Its 
activation leads to triacylglycerol production and accumulation in liver, differentiation and proliferation of 
adipocytes, increased synthesis of both adiponectin and resistin [2], and regulation of the immune system 
response via a reduction in inflammatory activity of lymphocytes [3, 4]. Peroxisome proliferator-activated 
receptor-gamma coactivator (PPARGC1A) is a transcriptional coactivator that regulates the genes involved in 
energy production [5]. Additionally, PPARGC1A is involved in NO-induced mitochondrial biogenesis, along 
with switching of muscle metabolism towards oxidative phosphorylation, thus adapting muscle tissue to 
endurance training [6]. A number of single nucleotide polymorphisms (SNPs) within the PPAR gene family are 
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associated with a predisposition to metabolic, cardiovascular, and neurodegenerative disorders, such as obesity, 
dyslipidemia, hypertension, cancer, type 2 diabetes, and Parkinson’s disease[7], [8].  
Obesity is a major problem within modern society, with the percentage of affected adults in 
comprising of up to 40% of the population in many developed countries[9]. Obesity is associated with an 
increased prevalence of cardiovascular diseases, type 2 diabetes, gastrointestinal and oncological disorders[10], 
[11]. Designing a personalized weight loss strategy may be an effective tool in reducing the spread of 
mentioned diseases [12]. 
To date, there is a limited data demonstrating the effects of SNPs within the genes of the PPAR family 
on weight loss through increased physical activity. PPARG polymorphisms are known to influence variability 
of body mass index (BMI) independently of sex, age, energy intake, and physical activity[13]. However, the 
effects of these polymorphisms on exercise-induced weight loss have not been previously characterized. The 
purpose of this study, therefore, was to identify SNPs within PPARG and PPARGC1A associated with the 
efficacy of moderate physical exercise on a weight loss in population of obese women.  
Materials and methods 
Participants 
The study participants were 39 Ukrainian middle-aged women (44.4±5.8 years of age), of which 32% had no 
previous physical activity experience. The inclusion criteria were: a BMI of greater than 30, and an absence of 
biochemical signs of severe metabolic syndrome (i.e. normal LDL, HDL, cholesterol and triglycerides). 
General characteristics of the study participants are shown in the Table 1. 
Intervention 
All participants were enrolled into a 3-month fitness program, which included 180 minutes of aerobic exercise 
per week with an average metabolic equivalent (MET) value of 6. Depending on the baseline physical fitness 
levels of each participant, exercise heart rate did not exceed 115–125 bpm (low fitness), 125–135 bpm 
(moderate fitness), or 135–145 bpm (well-adapted). Heart rate was measured using Polar RC3 GPS with Polar 
heart rate sensor H7 (Finland). Additionally, throughout the study period, the participants were advised to 
maintain a healthy hypocaloric diet (~1500 calories), avoid high-sugar, high-fat, and processed food diets, and 
to include more vegetables and wholemeal products in their diet. 
Anthropometric and Blood Measurements 
All blood and anthropometric measurements were done before and after the exercise lifestyle intervention. BMI 
was calculated as body weight in kilograms divided by the square of the height in meters. Percentage of total 
and visceral fat was measured by bioelectrical impedance analysis with “TANITA – BC-418MA” body 
composition analyser (Japan). For the blood biochemical test, blood samples were collected from the 
antecubital vein after an overnight fast. HDL, LDL, and triglycerides were measured via biochemical analyser 
«HYMALYZER 3000».  
Genotyping  
The samples of 39 subjects were sent to the commercial laboratory (Akesogen, UK), where DNA was extracted 
from the saliva samples using Qiagen chemistry on an automated Kingfisher FLEX instrument (Thermo Fisher 
Scientific, Waltham, MA, US), following the manufacturer’s recommended protocols and standard operating 
procedures. PicoGreen and Nanodrop measurements were taken to measure the quality and quantity of the 
DNA. Input to the custom testing array occurs at 200 ng in 20 μl. Amplification, fragmentation, and 
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resuspension was performed using Biomek FXP following Affymetrix’s high throughput protocol for Axiom 
2.0. Hybridization was performed for 24 hours at 48 °C in a Binder oven, and staining and scanning of the 
arrays (94 PPARG and 138 PPARGC1A SNPs; DNAFit’s custom microchips) were performed using GeneTitan 
instrumentation (Thermo Fisher Scientific, Waltham, MA, US), all following the same Affymetrix high 
throughput Axiom 2.0 protocol. Data analysis was then performed using a raw CEL file data input into the 
Affymetrix Axiom Analysis Suite (Affymetrix, Santa Clara, CA, US). 
Analysis of mRNA expression of PPARG 
RNA was obtained from blood plasma. The analysis of mRNA expression of PPARG was performed only at 
the start of the weight loss program. Expression of PPARG mRNA was measured via reverse transcription and 
amplification. Reverse transcription was performed with Random Hexamer primer, Revert Aid RT, Ribo Lock 
RNAse inhibitor and dNTP mixture on Gene Amp® PCR System 2700, Applied Biosystems, USA. The 
samples were incubated at 42°C for 1 h, followed by heating at 70°C for 10 min. Amplification was performed 
on a 7500 FastReal-time PCR system (Applied Biosystems, USA). The values were corrected for -actin 
mRNA expression. 
Statistical analysis 
Statistical analysis was conducted using RStudio software. One-way analysis of variance (ANOVA) was 
applied to determine statistical significance among different groups. The paired t-test was used to detect the 
significance of dynamic changes. P < 0.05 was considered statistically significant. Bonferroni’s correction for 
multiple testing was performed by dividing the P value by the number of tests where appropriate. 
Results 
Effects of intervention program 
The changes in body composition and biochemical profile in response to the 3-month exercise training and 
hypocaloric diet are summarized in Table 1. As expected, the intervention induced significant improvements of 
triglycerides, LDL, and cholesterol levels, as well as BMI, waist circumference, hip circumference, total and 
visceral fat. 
Influence of SNPs on PPARG mRNA expression 
The mean value of PPARG mRNA levels corrected for -actin mRNA expression was 38.3±1.73. Of the 94 
analysed PPARG SNPs, the only one SNP rs6442311 A/G within PPARG intron was associated with PPARG 
mRNA expression after correction for multiple testing. The rs6442311 AG genotype was associated with 
increased PPARG expression (9.01±0.07%; P = 0.022).  
Associations between PPARG and PPARGC1A SNPs and adipose tissue mass 
We evaluated relationships between 94 PPARG and 138 PPARGC1A SNPs and baseline values of body fat 
percentage, visceral fat, and markers of lipid metabolism (HDL, LDL, cholesterol). Of the tested PPARG 
SNPs, only one (rs6442311) of the 94 showed a significant (P = 0.016) influence on the initial percentage of 
body adipose tissue. For individuals with the AG genotype of rs6442311 the mean values of body fat 
percentage and visceral fat were 29.3% and 5.5% respectively. For individuals with the AA genotype, the 
results were 41.6 % and 10.5 %, respectively (Fig. 1). Accordingly, the minor allele of rs6442311 had a 
negative correlation with the accumulation of white adipose tissue, especially of visceral fat, and with a higher 
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ratio of total to visceral fat mass (5.33 for carriers and 3.96 for non-carriers). All genotypes frequencies are 
summarized in Table II. 
Of the 136 tested PPARGC1A SNPs, only rs6846769 showed a significant association with baseline percentage 
of adipose tissue (P = 0.034). More specifically, the minor allele was correlated with a lower body fat 
percentage; 41.4 % and 28 % for major and minor alleles, respectively (Fig.1). Furthermore, the percentage of 
visceral fat in minor allele carriers was almost two-times lower (9.7 % and 5 %), and the ratio of total adipose 
fat to visceral fat was higher in carriers (5.6) than in non-carriers (4.3).  
Associations between PPARGC1A SNPs and blood lipoproteins 
None of the 94 tested PPARG SNPs showed a statistically significant association with HDL, LDL, cholesterol 
or triglycerides. One of the 136 tested PPARGC1A SNPs showed a significant influence on blood lipoproteins. 
The minor allele of rs4458444 (intron variant) was associated with increased HDL (P = 0.0081), and total 
cholesterol (P = 0.036). One of the 136 tested PPARGC1A SNPs demonstrated correlation with increased 
triglyceride blood concentrations. A mean triglyceride concentration of 2.38 mM/l was found in carriers of 
rs2305681 minor allele, whereas the mean of carriers of major allele was 1.6 mM/l.  
Associations between PPARG and PPARGC1A SNPs and fat mass loss  
Only one polymorphism (rs17650401 C/T) within the PPARGC1A gene was found to be associated with fat 
loss efficiency after correction for multiple testing, with T allele carriers showing the greatest exercise-induced 
reduction in body fat percentage (2.5-fold; P=0.00013) compared to non-carriers. As for the 94 analyzed 
PPARG SNPs, rs9833097 (P=0.00023) and rs12629751 (P=0.0065) showed association with fat loss. 
Genotypes of rs9833097 (AA, AG, GG) were found to be associated with different degrees of weight loss 
(14.60 %, 4.71%, and 2.82%, respectively). Presence of the minor allele of rs12629751 was found to correlate 
with a twofold increase in weight loss after the three-month moderate exercise program: the percentages of 
body fat loss were 3.02 % and 6.48 % for CC and TC genotypes, respectively.  
Discussion 
The effectiveness of physical exercise and diet on fat loss varies considerably between individuals [13]. Our 
genetic association study was designed to test whether multiple variations in the PPARG and PPARGC1A 
genes can modulate changes in body composition and metabolic variables following a 3 months supervised 
fitness program and hypocaloric diet in obese Ukrainian women. We also tested the hypothesis that 
polymorphisms within PPARG gene may influence its expression. 
PPARG plays an important role in the control of adipose tissue metabolism, adipocyte division and 
differentiation, fat storage and oxidation in beige and brown adipose tissue [14]. Exercise is known to increase 
PPARG expression and activity within skeletal muscle, thus promoting mitochondrial biogenesis and aerobic 
respiration [15]. An increased expression of PPARG offers protection against elevated blood glucose 
levels[14]; as such, the rs6442311 G allele of the PPARG gene, which has been shown in our study to be 
associated with increased PPARG mRNA levels, may decrease the risk of obesity-induced diabetes and 
cardiovascular diseases. Indeed, we found that PPARG rs6442311 G allele was also associated with a decreased 
baseline percentage of visceral fat. 
Body fat and visceral fat percentage, and markers of lipid metabolism (HDL, LDL, cholesterol) are 
strongly related to the risk of metabolic syndrome, type 2 diabetes, and cardiovascular diseases [17]. Besides 
PPARG rs6442311, the rs6846769 polymorphism in the PPARGC1A gene showed a significant association 
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with baseline percentage of adipose tissue. The rs6846769 SNP may protect against the accumulation of 
visceral fat in an obese person under the influence of environmental factors via the activation of adaptive 
thermogenesis in brown adipose tissue[15]. This SNP is located in the first intron of PPARGC1A, prior to the 
protein coding sequence, and may participate in the control of PPARGC1A gene expression. Enhanced 
PPARGC1A expression protects from visceral adipose tissue accumulation, increases total adipose to visceral 
fat ratio, and reduces total body fat content[16]. Furthermore, the minor allele of the PPARGC1A gene 
rs4458444 polymorphism was associated with increased HDL and total cholesterol. Previously[17, 18] it was 
shown that decreased expression of PPARGC1A may upregulate liver lipoprotein synthesis and downregulate 
systemic utilization of cholesterol lipoproteins. In addition, the PPARGC1A rs2305681 SNP was found to be 
associated with triglyceride concentration. Decreased activity of PPARGC1A is associated with increased blood 
triglyceride levels[7] and risk of cardiovascular disease, especially under the influence of environmental factors 
which induce obesity. Previously, rs2305681 showed strong correlation with anxiety disorders[22] via possible 
activation of the antioxidant system within GABA neurons[19]. Interestingly, PPARGC1A rs3774909 (which is 
in 100% linkage disequilibrium (LD) with rs2305681) has been shown previously to be associated with 
endurance performance[20], presumably via regulation of oxidative phosphorylation, skeletal muscle 
mitochondrial biogenesis, and alteration of muscle fiber types.   
We have also shown that rs17650401 C/T within the PPARGC1A gene was associated with fat loss 
efficiency after correction for multiple testing. This is in line with the studies showing that various types of 
exercises (acute, high intensity interval, and aerobic) induce PPARGC1A expression in the group of overweight 
people[21], which was accompanied with fatty acid oxidation[22]. Moreover, the increased PPARGC1A 
activity was independent of the glycemic index of diet[23] and mostly induced by the exercise program. 
Furthermore, we found two candidate markers within PPARG (rs12629751 and rs9833097) that have 
shown association with fat loss. Interestingly, the minor allele of rs12629751, which correlated with a twofold 
increase in weight loss, previously demonstrated a protective property against breast cancer[24]. In addition, 
the polymorphism within rs7626560 (which is in LD with rs9833097) correlated with response to diabetes 
prevention lifestyle interventions[25], where participants were advised to perform 150 min of physical activity 
per week (in our study, participants exercised 180 min per week).  
All significant SNPs identified within this research are located in the intron region. The genotype 
frequencies of these SNPs are listed in Table II. There is no data about the intronic SNPs effects on 
PPARGC1A or PPARG expression. Hence, these SNPs may belong to regulatory post-transcriptional sequences 
producing miRNA. Also, a changing of the nucleotides upstream of promotor region may lead to another 
nucleosome positioning, thus altering promoter strength and its interaction with transcriptional factors. 
Altogether, we suggest this leads to a different expression response to the same environmental factors, such as 
diet, age and physical exercises; this hypothesis is illustrated on Fig 2. According to our model, intronic SNPs 
could change positioning of nucleosomes in cis-regulatory elements, which leads to the different sensitivity of 
PPARG promotor region to the transcriptional factors (C/ERB, STAT5A, CREB) that are affected by 
hypocaloric diet or physical activity[26, 27] and other factors like polyunsaturated fatty acids, prostaglandins, 
and eicosanoids. Thus, physical activity might have a different impact on PPARG expression and further 
adipose tissue metabolism depending on a particular SNP in the intronic region. 
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Conclusions 
An intervention comprised of physical activity and a hypocaloric diet has a significant impact on fat loss. 
Although no association was found between SNPs of PPARG gene and weight loss efficiency , individual 
variability in fat loss efficiency may partly depend on the rs17650401 C/T polymorphism within the 
PPARGC1A gene. The identified SNPs, along with many others, may be helpful in designing individual weight 
loss programs focused on exercise and/or nutrition. According to our results, we suggest that rs17650401 CT or 
TT genotype carriers can effectively improve BMI through moderate aerobic exercise and hypocaloric diet, 
while CC genotype carriers can obtain more benefits in weight loss from additional strength exercise or high-
intensity interval training and increasing of omega-3 polyunsaturated fatty acids dietary intake. These factors 
could have higher influence on PPARG gene and adipose tissue metabolism. Further studies are warranted to 
test whether this variation is associated with fat oxidation and with fat loss efficiency in other ethnicities. 
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TABLES 






Triglycerides, mM/l 1.58±0.78 1.47±1.04 0.756 
LDL, mM/l 3.21±1.16 2.86±0.98 0.016* 
HDL, mM/l 1.44±0.3 1.41±0.28 0.549 
Cholesterol, mM/l 5.32±1.23 4.81±1.08 0.022* 
BMI, kg/m2 33.2±2.9 30.4±3.7 <0.00001* 
 10 
Waist circumference, cm 92.4±8.9 85.9±8.9 <0.00001* 
Hip circumference, cm 115.3±7.1 107.9±7.7 <0.00001* 
Total fat, % 40.3±5.3 36.4±5.7 <0.00001* 
Visceral fat, % 9.5±2.4 8.1±2.2 <0.00001* 
Table II. – Genetic frequencies of identified SNP in population of 39 obese women 
 
SNPs 
Frequencies of a 
minor allele 
Genotypes frequencies 
rs6442311 0.026 AA 0.947 AG 0.053 GG 0.000 
rs6846769  0.013 AA 0.974 AC 0.026 CC 0.000 
rs4458444  0.013 GG 0.974 GA 0.026 AA 0.000 
rs17650401  0.064 CC 0.872 CT 0.128 TT 0.000 
rs9833097  0.192 GG 0.667 GA 0.308 AA 0.026 
rs12629751  0.115 CC 0.769 CT 0.231 TT 0.000 
rs3774909  0.051 CC 0.923 CT 0.051 TT 0.026 
 
 
TITLES OF FIGURES 
Figure 1.⎯ Associations between PPARG rs6442311 and PPARGC1A rs6846769 polymorphisms and 
percentage of total and visceral adipose tissue in obese women (BMI>30 kg/m2). 
Figure 2.⎯ Theoretical model of intron SNPs influence on PPARG expression under moderate-exercise 
environment. 
 
